Skip to content

Clinical trials

Phase 2 Lymphoma, B-Cell trials with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, B-Cell Phase: Phase 2 Status: Unknown status Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20151
20174
20183
20192
20201
20213
20223
20233

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status21

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Tel-Aviv Sourasky Medical Center2
The Affiliated Hospital of Xuzhou Medical University2
Chinese PLA General Hospital1
First Affiliated Hospital of Zhejiang University1
Fudan University1
Genor Biopharma Co., Ltd.1
Heidelberg University1
Hrain Biotechnology Co., Ltd.1
Huiqiang Huang1
Institute of Hematology & Blood Diseases Hospital, China1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, B-Cell21
Recurrence3
Immune System Diseases1
Immunoproliferative Disorders1
Leukemia, B-Cell1
Leukemia, Lymphocytic, Chronic, B-Cell1
Lymphatic Diseases1
Lymphoma1
Lymphoma, B-Cell, Marginal Zone1
Lymphoma, Large B-Cell, Diffuse1

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.